Zobrazeno 1 - 4
of 4
pro vyhledávání: '"maria Aquila Santoro"'
Autor:
Sisto Milito, Francesco Iuliano, Angelo Pomillo, Maria Luci, Eleonora Iuliano, Alessia Perricelli, Salvatore Palazzo, maria Aquila Santoro
Publikováno v:
Journal of Clinical Oncology. 36:e14566-e14566
e14566Background: CIT is provided with a platelet count < 100×109/μL with or without bleeding in cancer patients receiving chemotherapy .CIT can prevent the administration of the optimal dose and s...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::403dcdd2d3fea6aa3115f2cfc2aaa2d7
https://doi.org/10.1200/jco.2018.36.15_suppl.e14566
https://doi.org/10.1200/jco.2018.36.15_suppl.e14566
Autor:
Francesco Iuliano, Alessia Perricelli, Maria Luci, Pierosandro Tagliaferri, Angelo Pomillo, Pierfrancesco Tassone, Eleonora Iuliano, maria Aquila Santoro
Publikováno v:
Blood. 128:1269-1269
Rituximab, a monoclonal antibody directed against the CD20 antigen expressed on B cells, has been shown to be effective in AIHA, both in idiopathic and secondary including those associated with autoimmune and lymphoproliferative disorders as well as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f17a6299c1faee65d3ab0039b5f95ab1
https://doi.org/10.1182/blood.v128.22.1269.1269
https://doi.org/10.1182/blood.v128.22.1269.1269
Autor:
Pierosandro Tagliaferri, Maria Luci, Eleonora Iuliano, Francesco Iuliano, Pierfrancesco Tassone, Angelo Pomillo, maria Aquila Santoro, Alessia Perricelli
Publikováno v:
Blood. 128:4926-4926
Chemotherapy-induced-thrombocytopenia (CIT) can prevent the administration of the optimal dose and schedule of anticancer treatment and limit its benefits in the adjuvant or metastatic setting. Therapeutic approaches will include dose delays or reduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd00abddecd84f230e6c5d250e01263b
https://doi.org/10.1182/blood.v128.22.4926.4926
https://doi.org/10.1182/blood.v128.22.4926.4926
Autor:
Eleonora Iuliano, Maria Luci, Angelo Pomillo, Gian Luca Cervo, maria Aquila Santoro, Francesco Pontieri, Alessia Perricelli, Francesco Iuliano
Publikováno v:
Journal of Clinical Oncology. 34:e22539-e22539
e22539Background: Kaposi's sarcoma (KS) is a potentially life-threatening multifocal neoplasm that may represent a difficult therapeutic challenge in disseminated stages. Liposomal anthracyclines, or combination chemotherapy are widely used to treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f23b4a11970a72e005ed9493c8e9c68c
https://doi.org/10.1200/jco.2016.34.15_suppl.e22539
https://doi.org/10.1200/jco.2016.34.15_suppl.e22539